CLBS119 for Repair of COVID-19 Induced Pulmonary Damage

LLLT Treatment of Lung Inflammation in COVID-19

NCT04524715 ·Status: WITHDRAWN ·Phase: NA

Study to Evaluate the Safety and Tolerability of GBT440 Administered to Subjects With IPF

NCT02846324 ·Status: COMPLETED ·Phase: PHASE2

Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure

NCT04389840 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Low-Level Laser Therapy Treatment of Lung Inflammation in Post-COVID-19 Recovery

NCT05258617 ·Status: TERMINATED

SP16 as a Therapeutic for COVID-19 Induced ARDS

NCT05135624 ·Status: TERMINATED ·Phase: PHASE1

Garadacimab Safety, Pharmacokinetics, and Pharmacodynamics in Idiopathic Pulmonary Fibrosis

NCT05130970 ·Status: COMPLETED ·Phase: PHASE2

PH-797804 LPS Study in Healthy Volunteers

NCT02084485 ·Status: COMPLETED ·Phase: PHASE1

Testing the Efficacy and Safety of BIO101 for the Prevention of Respiratory Deterioration in COVID-19 Patients

NCT04472728 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Evaluate the Efficacy & Safety of Leronlimab in Patients With Severe or Critical COVID-19

NCT04347239 ·Status: COMPLETED ·Phase: PHASE2

Scleroderma Lung Disease

NCT00004563 ·Status: COMPLETED ·Phase: PHASE3

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

NCT04619680 ·Status: COMPLETED ·Phase: PHASE4

Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection

NCT04326036 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest

NCT02989168 ·Status: TERMINATED ·Phase: PHASE2

Effects of CSL324 in the Lung After Segmental Challenge

NCT05653713 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.

NCT07053423 ·Status: RECRUITING ·Phase: PHASE4

Study of the Safety of Therapeutic Tx With Immunomodulatory MSC in Adults With COVID-19 Infection Requiring Mechanical Ventilation

NCT04397796 ·Status: TERMINATED ·Phase: PHASE1

A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen

NCT01644877 ·Status: COMPLETED ·Phase: PHASE2

Leronlimab in Patients With Coronavirus Disease 2019 (COVID-19) With Need for Mechanical Ventilation or Extracorporeal Membrane Oxygenation

NCT04901689 ·Status: SUSPENDED ·Phase: PHASE3

Subcutaneous Sarilumab vs Placebo in Hospitalized Patients With Respiratory Distress Caused by COVID 19

NCT07196306 ·Status: WITHDRAWN ·Phase: PHASE2

Efficacy, Safety, Tolerability, and Biomarkers of Ibudilast (MN-166) in Patients Hospitalized With COVID-19 at Risk for ARDS

NCT04429555 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of Safety & Efficacy of BIO-11006 Inhalation Solution in Patients With ARDS

NCT03202394 ·Status: COMPLETED ·Phase: PHASE2

The Use of PUL-042 Inhalation Solution to Reduce the Severity of COVID-19 in Adults Positive for SARS-CoV-2 Infection

NCT04312997 ·Status: COMPLETED ·Phase: PHASE2

SVF for Treating Pulmonary Fibrosis Post COVID-19

NCT06304623 ·Status: COMPLETED ·Phase: PHASE1

Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation

NCT01916577 ·Status: COMPLETED ·Phase: PHASE1

Phase 2 Trial Using rhDNase to Reduce Mortality in COVID-19 Patients With Respiratory Failure

NCT04445285 ·Status: RECRUITING ·Phase: PHASE2